News
Perimeter announces positive topline results from the pivotal study designed to measure the effectiveness of the B-Series OCT system with ImgAssist AI during breast-conserving surgeries. The primary endpoint was met indicating a statistically significant reduction in patients with residual cancer during surgery.
News
Perimeter will report topline results from its pivotal study evaluating the use of the B-Series and ImgAssist AI during breast-conserving surgeries. The announcement will be made after market close on November 20, 2024, followed by a webcast and conference call hosted by Perimeter management to discuss the results.
News
Perimeter will host a conference call to discuss corporate updates and financial results for its third quarter after market close on November 14, 2024.
News
Perimeter announces the second closing of its non-brokered private placement, issuing 4,846,501 Common Shares at $0.42 per share for gross proceeds of $2,035,530, bringing the company's total number of issued Common Shares to 28,317,061 and aggregate gross proceeds to $11,893,166.
News
Perimeter announces the completion of patient enrollment in a pivotal study evaluating the use of its next-generation Perimeter B-Series OCT system, combining proprietary AI technology with optical coherence tomography during breast-conserving surgeries.
News
Perimeter announces the closing of its non-brokered private placement of 23,470,560 Common Shares at a price of $0.42 per Common Share, for gross proceeds of $9,857,635.